Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
BioNTech SE - ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:PFE) after the company issued FY23 guidance below estimates. Also, the Biden Administration said it plans to end COVID-19 emergency declarations on May 11.
See Also: Biden Administration Plans To End COVID-19 Public Health Emergency In May
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Pfizer's FY23 Outlook
Pfizer forecasts FY23 sales to fall to $67-$71 billion from $100 billion in 2022 versus the consensus of $74.13 billion.
The company expects adjusted EPS guidance of $3.25-$3.45, down from $6.58 in 2022 and the consensus of $4.44...Read More
According to data from Benzinga Pro:
- BNTX shares are trading lower by 2.63% to $136.80
- MRNA is lower by 2.69% to $176.00
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.